Sort by
Refine Your Search
-
Contributions Contribute to the continued development and maintenance of UXarray, including analysis operators, grid subsetting, remapping, and plotting capabilities for unstructured mesh data. Help develop and
-
for Heterogeneous Integration of Micro Electronics Systems (CHIMES). For additional information about CHIMES, please click here . Requirements and Qualifications: A PhD in Electrical Engineering, Materials Science
-
concentrating on advanced batteries and fuel cells for vehicle electrification, renewable energy storage, and power grids Qualifications and Requirements: Ph.D. in Chemistry, Chemical Engineering, Materials
-
cells for vehicle electrification, renewable energy storage, and power grids The group is known for cross-fertilization of electrochemistry, materials, manufacturing, diagnostics, CFD modeling, and system
-
markers of leukemia patients and incorporate molecular biology techniques including micro-RNA to correlate with leukemia pathogenesis. In addition, candidates need to work on clinical trial management which
-
mechanisms that control RNA polymerase pausing and termination, regulation of gene expression by transcription attenuation and translational control mechanisms, structural studies of RNA polymerase using cryo
-
and metabolic stress signaling in cancer metastasis. Our goal is to reveal how the mitochondrial metabolism and nutrient stress controls metastatic progression through epigenetic remodeling
-
computationally efficient reduced-order dynamical systems on graph with modern power grid systems as an application. Education and Experience: Applicants must have recently completed a Ph.D. and have exceptional
-
, protein-RNA interaction, protein-protein interaction, and/or bioinformatics analysis of transcriptomics data is required. The successful candidate will explore fundamental mechanisms that control RNA
-
signaling and metabolic vulnerability in metastatic cancer. Our goal is to reveal how the mitochondrial metabolism and nutrient stress controls metastatic progression through metabolic reprogramming